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Background. Kaposi sarcoma-associated herpesvirus (KSHV) establishes lifelong infection in the human host and has been 
associated with a variety of malignancies. KSHV displays striking geographic variation in prevalence, which is highest in sub-Sa-
haran Africa. The current KSHV genome sequences available are all tumor cell line-derived or primary tumor-associated viruses, 
which have provided valuable insights into KSHV genetic diversity.
Methods. Here, we sequenced 45 KSHV genomes from a Ugandan population cohort in which KSHV is endemic; these are the 
only genome sequences obtained from nondiseased individuals and of KSHV DNA isolated from saliva.
Results. Population structure analysis, along with the 25 published genome sequences from other parts of the world, showed 
whole-genome variation, separating sequences and variation within the central genome contributing to clustering of genomes by 
geography. We reveal new evidence for the presence of intragenic recombination and multiple recombination events contributing to 
the divergence of genomes into at least 5 distinct types.
Discussion. This study shows that large-scale genome-wide sequencing from clinical and epidemiological samples is necessary 
to capture the full extent of genetic diversity of KSHV, including recombination, and provides evidence to suggest a revision of KSHV 
genotype nomenclature.
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Kaposi sarcoma-associated herpesvirus (KSHV) also known as 
human herpesvirus-8 (HHV-8) was first discovered by Chang 
and colleagues in 1994 as the etiological agent of Kaposi sar-
coma (KS) [1, 2]. KSHV-associated diseases predominantly 
occur in immunosuppressed individuals [3], with widespread 
human immunodeficiency virus (HIV) infection driving the KS 
epidemic, especially in sub-Saharan Africa. KSHV is also found 
to be associated with lymphoproliferative disorders, particularly 
primary effusion lymphoma (PEL) and multicentric Castleman 
disease [1, 4], and, more recently, KSHV inflammatory cyto-
kine syndrome (KICS) in individuals with HIV coinfection [5]. 
Virus transmission is mainly via saliva [6, 7]; however, other 
modes of transmission have been reported [8].
Within 2  years of its discovery, the first KSHV genome 
sequence BC-1 was determined from a PEL cell line, revealing 
an approximately 165-kb dsDNA genome with an approximately 
140-kb long unique coding region [9]. The KSHV genome map 
has changed little since its discovery, with the annotation of the 
GK18 sequence revealing 86 genes, of which 22 encode putative 
immunomodulatory proteins [9–11]. The KSHV genome shows 
high conservation with up to 99% sequence identity between 
viral strains; however, both 5′ and 3′ ends of the genome have 
higher sequence variability and as such have been used to char-
acterize viral strains [12]. ORF K1 located at the 5′ termini of 
the genome encodes a highly glycosylated transmembrane pro-
tein, with hypervariable regions (V1 and V2) with up to 30% 
amino acid variability, resulting in 7 major K1 subtypes, A–E 
and more recently F [12–15]. The P (predominant), M (minor), 
and N genotypes of KSHV arise from the K15 gene at the 3′ ter-
mini of the genome, a gene that encodes an integral membrane 
protein with up to 30% sequence identity at the amino acid 
level [16–18]. While the central region of the KSHV genome is 
highly conserved, 9 discrete loci with lower levels of variation 
compared to K1 and K15 have also been used in a number of 
phylogenetic studies for subtype characterization [18].
Prior to recent developments in next-generation sequenc-
ing technologies, large scale whole-genome comparisons were 
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not feasible. A recent study, conducted by Olp and colleagues 
sequenced 16 whole genomes directly from skin lesions of 
Zambian KS patients [19]. They showed that low-level genetic 
variation in the central conserved genome region contributes 
to a unique phylogenetic structure, with distinct genomic vari-
ants from Zambian isolates compared to Western (United States 
and Greece) isolates [19]. These types of genome-wide sequenc-
ing studies allow us to account for the remaining >90% of the 
genome to further understand the diversity of KSHV at the 
whole-genome level.
With the current genome sequences from only 4 countries 
(United States [9, 20–22], Greece [10], Zambia [19] and most 
recently Japan [23]), and all from individuals with KSHV-
associated diseases, we are now beginning to understand the 
extent of KSHV genomic diversity. While very important ground 
work has been laid by these previous studies, no genomes have 
been obtained from asymptomatic persistently infected indi-
viduals and thus nontumor-associated KSHV genomes have 
never been characterized. Here, we performed whole-genome 
sequencing of KSHV from saliva of Ugandan individuals free of 
KSHV-associated disease, and assessed the variability between 
KSHV sequences isolated from different sources, including dis-
eased individuals and patients from diverse geographic origins. 
In addition, we explored the presence of inter- and intragen-
otype recombination within the Uganda General Population 
Cohort (GPC) [24] and in a wider context.
Uganda is a good country to study molecular epidemiology and 
phylogeography of KSHV, as it is inhabited by different ethnolin-
guistic groups with divergent historic origins as a result of migra-
tion over several hundred years from surrounding regions [25]. 
In addition, the population has the highest reported seropreva-
lence of KSHV in the world [26–28]. In the GPC, the seroprev-
alence of KSHV is >90%. Several studies conducted in Uganda 
have provided valuable insights into KSHV seroepidemiology 
and transmission [6, 7, 29–32], therefore characterizing genetic 
diversity on a genome-wide level will provide invaluable 
insights to further our understanding of KSHV diversity and 
its evolution.
METHODS
Sample Collection and Ethics
The GPC is a population-based cohort in rural south-west 
Uganda consisting of 25 neighboring villages mainly inhabited 
by peasant farmers [24]. Households are scattered with some 
concentrated in the trading centers. Saliva samples (N = 2036) 
were collected from asymptomatic individuals during med-
ical survey round 24 between January and July 2015. Saliva 
(2 mL) was collected with the Oragene DNA self-collection kit, 
OMNIgene ORAL OM-505 (DNA Genotek, ON, Canada) fol-
lowing manufacturer’s instructions and stored at −80°C prior to 
shipment on dry ice to the Sanger Institute. Informed consent 
was obtained for genetic testing from participants either with 
signature or a thumb print if the individual was unable to 
write. The study was approved by the Uganda Virus Research 
Institutes, Research Ethics Committee (Ref. GC/127/10/10/25), 
the Uganda National Council for Science and Technology, 
and the UK National Research Ethics Service, Research Ethics 
Committee (Ref.11/H0305/5).
DNA Extraction and Purification
All sample preparation was performed in class II biosafety cab-
inets using aseptic techniques. Saliva samples were lysed and 
RNA removed with proteinase K (600 mAU/mL) Buffer VXL 
solution and RNase A  (100 mg/mL) treatment (Qiagen, UK). 
Aliquots of lysates (200  μL) were then extracted using the 
QIAamp 96 DNA QIAcube HT robot following the manufac-
turer’s protocol, and the remainder stored at −80°C.
Viral DNA Quantification
Quantitative polymerase chain reaction (qPCR) targeting the 
KSHV ORF73 gene was used for viral genome detection and 
determination of viral genome load. This was measured by 
determining the viral copy number relative to a 10-fold dilu-
tion of control BCBL-1 DNA against a standard curve with a 
detection range of 3 × 106–10 copies/mL (cycle threshold [Ct] 
of 15 to 43). Out of the 2036 samples, 746 were processed in 
duplicates using the QuantiTect Muliplex PCR kit (Qiagen, UK) 
on a Stratagene Mx3005P (Agilent Technologies, UK). Primers 
and probes targeting ORF73 (Metabion international AG, 
Germany) were designed for viral detection using sequences 
from Lallemand et al [33]. Glyceraldehyde-3-phosphate dehy-
drogenase was used to assess DNA quality with sequences from 
Pardieu et  al [34]. Primer-probe mixes were diluted to a 20× 
solution and following the qPCR conditions from Lallemand 
et  al [33]. Data analysis was performed using MxPro v4.10 
qPCR software (Agilent Technologies).
KSHV Whole-Genome Sequencing
The low abundance of viral DNA compared to the host DNA, 
along with the large KSHV genome, makes sequencing of 
KSHV quite challenging, therefore, in this study we sequenced 
whole genomes from 244 samples with detectable viral DNA 
(Ct values  <  36) using the SureSelect method (version 1.1; 
Agilent Technologies) [35]. Excluding repeat regions, baits were 
designed to include all published KSHV genomes sequenced 
from PELs (BCBL-1, BC-1, JSC-1, VG-1). Samples were mul-
tiplexed on an 8-lane flow cell with 24 samples per lane; clus-
ter generation and sequencing was performed on an Illumina 
HiSeq 2500 sequencer. Sequencing reads were 250-bp paired 
ends in FASTQ format with per base Phred quality scores.
Guided Assembly of KSHV Whole Genomes
The QUASR QC pipeline (http://sourceforge.net/projects/
quasr) [36] was used to retain high-quality full-length reads. 
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Duplicate reads and paired reads with a raw median Phred 
quality score Q < 32 were either filtered out or trimmed from 
the 3′ end until Q > 32, reads less than 100 bp post trimming 
were also excluded. High-quality paired-end reads post-QC 
were then mapped back to GK18 and BC1 reference sequences 
using Burrows-Wheeler Aligner (BWA) [37] and the depth and 
coverage calculated using SAMTools [38]. Pairwise-correlation 
was calculated using Pearson correlation in R for qPCR viral 
load, KSHV mapped reads (%), and sequencing depth.
Comparative Sequence and Population Structure Analysis
For comparative sequence analysis we selected sequences from 
45 Ugandan individuals with an average sequencing depth 
of >20×, and aligned them with 25 publicly available KSHV 
genomes using MAFFT [39] (v7.0) and viewed them using 
AliView software. Repeat regions across the alignment were 
masked with coordinates retrieved from the GK18 reference 
sequence annotation in Genbank (NC_009333). Genome-
wide mutations relative to the GK18 reference sequence 
were visualized in a 1000-nucleotide (nt) scanning window. 
Principal components analysis (PCA) was performed on all 
single-nucleotide polymorphisms (SNPs) in the genomes using 
the scikit-learn package implemented in ScientificPython. 
Phylogenetic analysis was performed following alignment of 
the coding sequences of the K15 gene and K1 gene along with 
representative sequences (Supplementary Table 1). The align-
ments were used to infer trees using maximum-likelihood 
methods implemented in RAxML (v8) with 1000 bootstrap 
replicates under a general time reversible model of nucleotide 
substitution and including a Gamma distribution for among 
site rate variation [40].
Recombination Analysis
To identify conflicting phylogenetic signals, Neighbor-net split 
networks were constructed with SplitsTree 4.14 [41], using 
the Uncorrected_P characters’ transformation and excluding 
gap sites. To calculate a measure of statistical significance for 
recombination we used the phi test, which has been proven to 
give reliable results for conserved DNA sequences [42]. To iden-
tify recombination and potential breakpoints we used Kishino 
Hasegawa test (P <  .05) and the Akaike information criterion 
for goodness of fit implemented by the Genetic Algorithm 
Recombination Detection program (GARD) [43]. Further sta-
tistical support were provided by using the algorithms imple-
mented in RDP4 suite [44] with default settings. Bootscan 
analysis was also performed across the genomes using the 
SimPlot program [45] with a window size of 4000 nt and a 1000 
nt step size with a bootstrap cutoff of 70%.
Data Deposition
The sequencing data from this study has been submitted to 
the European Nucleotide Archive (http://www.ebi.ac.uk/ena) 
under the accession numbers listed in Table 1.
RESULTS
Characteristics of Samples Used in This Study
We sequenced 244 out of 746 (32.7%) Ugandan samples with 
detectable KSHV viral load (range: 5.35 × 105 to 1.5 copies/mL). 
Viral load was strongly positively correlated with the percentage 
of mapped reads (r2 = 0.84) and a high viral load was positively 
correlated with achieving good (ie, >20-fold) mean sequencing 
depth with >90% coverage across the genome. Out of the 244 
samples, 45 (18.4%) had > 20-fold coverage per genome nucle-
otide and these corresponded to the samples with the highest 
viral loads (104–105 copies/mL). They were collected from 8 
neighboring villages (12–19) in the GPC study area [24], con-
sisting of 21 men and 24 women between the ages of 16 and 
86  years (mean  ±  S.D,  41.65  ±  20.69). Five individuals were 
also HIV positive. Sample details for all 45 new GPC genome 
sequences are presented in Supplementary Table 2.
KSHV Genome Variability Analysis
To determine how variable the 45 GPC KSHV genomes were 
and explore which parts of the genome were contributing to the 
most variation, we performed a multiple sequence alignment 
including the 25 previously published KSHV genome sequences 
from (Table 1). The proportion of variants to the GK18 refer-
ence sequence were determined within a 1000-nucleotide slid-
ing window. Consistent with previous findings, this showed 
approximately 35% of all nucleotide substitutions were at the 
5′ end of the genome, which corresponds to the K1 gene, and 
approximately 60% were at the 3′ end of the genome, corre-
sponding to the K15 gene, with modest variation observed 
across the central regions of the genome (Figure 1). The total 
number of SNPs between each of the KSHV genomes can be 
seen in detail in Supplementary Figure 1 ordered by sequence 
identity to GK18.
Virus Genome-Wide Population Structure Analysis
To investigate the population structure of the 45 new genomes 
from Uganda in a wider context, we performed a PCA along 
with the 25 previously published strains. PC1 separated strains 
clearly into the 2 distinct types (Figure 2A), which have been 
previously classified as the type P and type M strains based on 
variation in the K15 gene and was the greatest contributor to 
the variance observed (32%). In addition, within each type, the 
Western samples (ie, GK18, BCBL-1, JSC-1, and DG-1) and 
Japanese samples cluster separately from the African samples 
(ie, Zambia and Uganda) and neither showed separation by 
country on PC2. We observed no distinct clustering of samples 
by strain in the respective villages. In addition, the PCA showed 
no distinct clustering patterns between genomes isolated from 
saliva compared to other sources, or between samples from 
asymptomatic versus diseased.
To assess the contribution of K1 and K15 genes to population 
structure, we realigned the genomes of all the samples excluding 
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Table 1. Characteristics of Samples Used in This Study
Name Origin K15 Type K1 Type New Typea Sample Source HIV Statusb Clinical Presentation Accession Number Ref.
UG110 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615765 …
UG114 Uganda P A5 P2 Saliva 0 Asymptomatic ERS1615766 …
UG117 Uganda P C1 P2 Saliva 0 Asymptomatic ERS1615774 …
UG118 Uganda M B1 M1 Saliva 0 Asymptomatic ERS1615777 …
UG119 Uganda M A5 M1 Saliva 0 Asymptomatic ERS1615780 …
UG12 Uganda P B1 P1 Saliva 1 HIV + asymptomatic ERS1615738 …
UG120 Uganda P B1 P2 Saliva 0 Asymptomatic ERS1615783 …
UG125 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615800 …
UG126 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615707 …
UG128 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615712 …
UG129c Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615715 …
UG13 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615741 …
UG131c Uganda M B1 M2 Saliva 0 Asymptomatic ERS1615723 …
UG132 Uganda P A5 P2 Saliva 0 Asymptomatic ERS1615725 …
UG133 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615727 …
UG134 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615730 …
UG136 Uganda P B3 P2 Saliva 0 Asymptomatic ERS1615737 …
UG137 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615744 …
UG141 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615761 …
UG145 Uganda M A5 M1 Saliva 0 Asymptomatic ERS1615775 …
UG146 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615778 …
UG148 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615784 …
UG149 Uganda P A5 P2 Saliva 0 Asymptomatic ERS1615786 …
UG15 Uganda M A5 M1 Saliva 0 Asymptomatic ERS1615748 …
UG151 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615793 …
UG152 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615795 …
UG155 Uganda P B1 P2 Saliva 0 Asymptomatic ERS1615706 …
UG156 Uganda P C1 P1 Saliva 1 HIV + asymptomatic ERS1615711 …
UG157 Uganda M C1 M1 Saliva 1 HIV + asymptomatic ERS1615714 …
UG158 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615719 …
UG159 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615721 …
UG16 Uganda M A5 M1 Saliva 1 HIV + asymptomatic ERS1615752 …
UG160 Uganda M B1 M2 Saliva 0 Asymptomatic ERS1615722 …
UG162 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615729 …
UG163 Uganda P B1 P1 Saliva 0 Asymptomatic ERS1615732 …
UG164 Uganda P A5 P2 Saliva 0 Asymptomatic ERS1615736 …
UG165 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615740 …
UG166 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615743 …
UG168 Uganda P B1 P1 Saliva 1 HIV + asymptomatic ERS1615750 …
UG212 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615837 …
UG219 Uganda M B4 M1 Saliva 0 Asymptomatic ERS1615860 …
UG222 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615807 …
UG226 Uganda P A5 P1 Saliva 1 HIV + asymptomatic ERS1615813 …
UG237 Uganda M B4 M2 Saliva 0 Asymptomatic ERS1615851 …
UG244 Uganda P A5 P1 Saliva 0 Asymptomatic ERS1615861 …
BC1 United States M A2 M1 B-cell line 0 PEL U75698.1 [9]
BCBL1 United States P A3 P1 B-cell line 0 PEL HQ404500.1 [20]
DG1 United States P A5 P1 Blood 0 KICS JQ619843.1 [22]
GK18 Greece P C3 P1 KS biopsy 1 Classic KS AF148805.2 [10]
JSC1 United States P C3 P1 B-cell line 0 EBV + PEL GQ994935.1 [21]
ZM004 Zambia P B1 ? KS biopsy 1 Classic KS KT271453 [19]
ZM027 Zambia P B1 P2 KS biopsy 1 Classic KS KT271454 [19]
ZM091 Zambia P A5 P2 KS biopsy 1 Classic KS KT271455 [19]
ZM095 Zambia N B4 N KS biopsy 1 Classic KS KT271456 [19]
ZM102 Zambia P B4 P2 KS biopsy 1 Classic KS KT271457 [19]
ZM106 Zambia P B1 P1 KS biopsy 1 Classic KS KT271458 [19]
ZM108 Zambia P B4 P2 KS biopsy 1 Classic KS KT271459 [19]
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the K1 and K15 genes and re-examined the PCA. While the 
clustering by type (P vs M) was lost, geographical clustering 
was observed with the Western and Japanese genomes clustered 
together and away from the African genomes (Figure 2B). This 
showed that genes in the central region were the major contrib-
utors to the geographical clustering observed.
Genotypic Diversity of Strains in the GPC
Because the K1 and K15 genes have been used for virus type 
classification we generated trees for each gene to determine the 
genotypes circulating in the 45 Ugandan samples. For the K15 
phylogenetic analysis, clear separation was observed between 
the strains types P and M; most Ugandan samples (78%) 
grouped with the type P strain, while 22% of samples grouped 
with the type M, and none of the GPC samples belonged to the 
type N strain (Supplemental Figure 2 and Table 1). The major 
types observed in the K15 phylogenetic tree are also consistent 
with the clustering identified in the PCA (Figure 2A)
For the K1 phylogenetic analysis, we aligned the 70 
genomes with K1 genes for the previously described genotypes 
(Supplementary Table 1). Of the 45 Ugandan GPC samples, 40% 
grouped with B genotypes, 53% grouped with the A genotype, 
and 7% grouped with the C genotype (Supplemental Figure 3 
and Table 1). While the B genotypes displayed heterogeneity in 
subtypes, clustering mainly with B1 and B3, all the A genotypes 
grouped with the A5 subtype.
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Figure 1. Whole-genome variation across 70 genomes. Line graph plotted across the genome showing the proportion of variant bases in a 1000-nucleotide (nt) sliding 
window where at least 1 Kaposi sarcoma-associated herpesvirus genome sequence has a single nucleotide polymorphism relative to the GK18 reference sequence. Grey 
bars indicate masked-out repeat regions.
Name Origin K15 Type K1 Type New Typea Sample Source HIV Statusb Clinical Presentation Accession Number Ref.
ZM114 Zambia P B3 P2 KS biopsy 1 Classic KS KT271460 [19]
ZM116 Zambia P B4 P1 KS biopsy 1 Classic KS KT271461 [19]
ZM117 Zambia P B4 P2 KS biopsy 1 Classic KS KT271462 [19]
ZM118 Zambia P B1 P1 KS biopsy 1 Classic KS KT271463 [19]
ZM121 Zambia P B1 P2 KS biopsy 1 Classic KS KT271464 [19]
ZM123 Zambia P B1 P1 KS biopsy 1 Classic KS KT271465 [19]
ZM124 Zambia P B1 P1 KS biopsy 1 Classic KS KT271466 [19]
ZM128 Zambia N B1 N KS biopsy 1 Classic KS KT271467 [19]
ZM130 Zambia P B3 P2 KS biopsy 1 Classic KS KT271468 [19]
Japan1 Japan M C3 M1 Cell line 0 Non-AIDS KS LC200589 [23]
Miyako1 Japan M C3 M1 KS biopsy 0 Non-AIDS KS LC200586 [23]
Miyako2 Japan M C3 M1 KS biopsy 0 Non-AIDS KS LC200587 [23]
Miyako3 Japan M C3 M1 KS biopsy 0 Non-AIDS KS LC200588 [23]
Abbreviations: EBV, Epstein-Barr virus; KICS, Kaposi sarcoma-associated herpesvirus inflammatory cytokine syndrome; KS, Kaposi sarcoma; PEL, primary effusion lymphoma.
aBased on whole-genome data.
bHIV status: 0, negative; 1, positive.
cBelong to the same household.
Table 1. Continued
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Recombination Analysis
To identify conflicting phylogenetic signals representative of 
evolutionary splits potentially due to recombination, we gen-
erated a split network based on all 70 genomes. Phylogenetic 
incongruences were illustrated by parallel internal branches, 
which is typical when there are several recombination 
events and/or convergent evolution. This analysis revealed 
the subgrouping of samples into 5 potentially distinct types 
labeled P1, P2, M1, M2, and N (Figure  3), as opposed to 
the original K15 classification into only 3 types: P, M, and 
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Figure 2. Principal component analysis (PCA) separates strains by type and geographic origin. PCA of all Kaposi sarcoma-associated herpesvirus (KSHV) strains (45 new 
strains and 25 published strains) based on single-nucleotide polymorphisms relative to the GK18 reference sequence in a full-genome multiple-sequence alignment. A, 
Principal component 1 (PC 1) separates all strains based on type P (blue dotted circle) and type M (green dotted circle). B, PCA of central genome minus variable K1 and K15 
genes shows some geographic clustering of KSHV strains, with separation of the African strains (black and red) compared to Western (blue) and Japanese (green).
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N (Supplementary Figure  2), and 1 outlier, ZM004, which 
could be either a potential recombinant or novel type that 
has not been well sampled. A  phi test provided strong sta-
tistical evidence of recombination (P < .00001) over conver-
gent evolution. Furthermore, a neighbor-net split network of 
the genomes minus the K1 and K15 genes also show strong 
evidence of recombination (Supplementary Figure  4) and 
highlight the contribution of central parts of the genome to 
diversity and population structure (similarly to the PCA in 
Figure 2B).
Figure 3. Neighbor-net phylogenetic network based on complete genomes of all 70 Kaposi sarcoma-associated herpesvirus samples. Parallel edges depict conflicting 
phylogenetic signals. The samples clustered into 5 distinct types (dotted circles) designated types P1, P2, M1, M2, and N, and 1 outlier ZM004, which did not cluster well 
with any type and thus may be a putative intertype recombinant or a novel type. The tips are labeled to represent sample geographic origin: black (Uganda), red, (Zambia), 
blue (Western), and green (Japan).
Table 2. Kaposi Sarcoma-Associated Herpesvirus Genes With Evidence of Recombination
Gene GARDa Phi test RDP4 Breakpoint (Bootstrap Support) Alignment length, Codons
K1 Yes Yes Yes 362(0.71) 867
ORF4 Yes Yes Yes 475 (0.86) 1650
ORF6 Yes Yes No 1622 (0.18) 3399
ORF9 Yes Yes Yes 408 (0.99) 3036
ORF11 Yes Yes Yes 462 (0.51) 1221
ORF21 Yes Yes Yes 931 (0.68) 1740
ORF48 Yes Yes No 909 (0.95) 1206
ORF64 Yes Yes Yes 6561 (0.35) 7905
Abbreviations: AICc, Akaike information criterion; GARD, genetic algorithm recombination detection; KH, Kishino Hasegawa; ORF, open reading frame.
aGARD: both AICc and KH significant, Phi-test: P < .05, RDP4: breakpoints with P < .05 and supported by at least 2 methods (RDP, GENECONV, MAXCHI, CHIMAERA, BOOTSCAN, SISCAN, 
3SEQ).
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Further resolving the extent of recombination events of 
KSHV is nontrivial owing to high conservation of KSHV 
genomes. Topological incongruences were identified by exam-
ining the trees generated by GARD either side of the confirmed 
breakpoint and using the phi test (P < .05) and RDP4 (>2 meth-
ods) we confirmed significant evidence of intragenic recom-
bination within 8 (K1, ORF4, ORF6, ORF9, ORF11, ORF21, 
ORF48, and ORF64) (Table 2) out of 86 genes that potentially 
contribute to inter- and intratype recombination that are pres-
ent across genomes.
To analyze the degree of genome fragmentation and visualize 
potentially shifting phylogenetic relationships, we generated a 
consensus sequence for each of the 5 types (P1, P2, M1, M2, 
and N) and, along with the ZM004 outlier genome, performed 
bootscan analyses using Simplot and statistical support pro-
vided by the RDP4 suite. These analyses showed strong support 
for intertypic recombination as displayed by the fragmentation 
across the genomes, suggestive of multiple recombination events 
over time (Figure 4A and Supplementary Figure 5). Particularly, 
the type M2 genomes, which show high identity (few SNPs) 
with ZM004, displayed conflicting phylogenetic signals with 
2 recombination breakpoints (Figure  4A). As shown in the 
bootscan plot, clustering of the type M2 with ZM004 changes 
at approximate positions 105 000 and 140 000, substantiating 
the presence of recombination with a type P2 genome and type 
M1 genome, respectively (Figure  4A). Split networks showed 
conflicting phylogenetic signals within each type, with the phi 
test showing statistically significant evidence of recombination 
(P < .05), which was confirmed by bootscan analysis in Simplot. 
For example, ZM091 a strain and outlier in the Neighbor-net 
tree (Figure 3) and potentially belonging to the P2 type, showed 
multiple recombination crossovers (Figure 4B).
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Figure 4. Evidence for recombination between different Kaposi sarcoma-associated herpesvirus types. A, Intertypic recombinant type M2. Bootscan plot comparing type 
M2 query with consensus sequence of types P2 (red), P1(green), M1(yellow), N (purple), and ZM004 (orange). B, Intratypic recombinant ZM091. Bootscan plot comparing 
ZM091 with consensus sequences of types P2 (red), P1(green), and ZM004 (orange). Shifting phylogenetic signals and fragmented genomes are indicative of the presence 
of recombination.
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DISCUSSION
Genome-wide sequence analyses of viruses have become cen-
tral to enhancing our understanding of the biology and epi-
demiology of viruses. Previous genetic analyses of KSHV 
genomes generated from KS, PEL, and KICS samples have pro-
vided invaluable insights into KSHV genomic architecture [9, 
10, 19, 22], and laid the groundwork for comparative genom-
ics; however, they may not be representative of those found 
in the general disease-free population. Here, we performed a 
comparative genomic variation and recombination analyses of 
the 45 new KSHV genomes, together with 25 previously pub-
lished genomes from Greece, United States, Zambia, and Japan 
(Table 1) and present novel evidence of pervasive recombina-
tion throughout the genome.
Studies using saliva pose a significant challenge for virus 
genome sequencing given the virus is difficult to detect, par-
ticularly in asymptomatic individuals unless they are actively 
shedding virus. For oncogenic herpesvirus, viral levels are 
much lower in saliva and blood compared to tumor biopsies 
or tumor-derived cell lines, which may explain the paucity of 
virus genomes from healthy individuals. We and others have 
used virus genome capture and sequencing to sequence vari-
cella zoster virus (VZV) [46], Epstein-Barr virus (EBV) [35, 47], 
HCMV [48], and now KSHV [19]. Our threshold for high-qual-
ity KSHV sequencing by target capture of >104 genome copies/
mL allowed us to derive hitherto unobtainable genome-wide 
sequences.
While the type P/type M classification, based on variation in 
the K15 gene, remained the major form of variation correlating 
with whole-genome clustering, the central genome region con-
tributed to geographic clustering of samples in this study, con-
sistent with the Zambian KS study [19]. Geographic association 
of K1 genotypes has been reported by several studies globally 
and our findings are consistent with previous studies of African 
strains; however, with intragenic recombination occurring in 
K1, phylogenetic relationships previously described may not be 
accurate. The heterogeneous distribution of KSHV genotypes 
throughout all villages, suggesting cross-village transmission, is 
not surprising given how well connected the villages are, with 
relaxed administrative boundaries enabling ease of access and 
movement between villages [24]. However, to reliably identify 
transmission patterns in this study, more household samples 
across age groups would be required.
Most strikingly, we observe strong statistical evidence of mul-
tiple recombination events across the KSHV genome leading to 
the grouping of samples into at least 5 distinct types. While these 
types broadly reflect the population structure associated with 
the K15 gene, it is evident that the genotyping based on the K15 
gene along with the K1 gene does not robustly capture genetic 
diversity. While previous KSHV studies have reported the pres-
ence of genetic recombinants driven by multiple recombination 
events [16, 28], breakpoints could not be accurately assessed 
because the distances between the genes sequenced were too 
great. Here, we identify 8 genes with recombination and show 
evidence of shifting phylogenetic signals with recombination 
crossovers present throughout the KSHV genomes suggestive 
of pervasive recombination and potentially novel types, con-
sistent with other examples occurring in EBV, herpes simplex 
virus (HSV), and VZV genomes [46, 47]. The KSHV genome 
is more conserved than those of EBV, VZV, HSV-1, and HSV-
2, therefore it is challenging to accurately infer recombination 
between similar parental strains or classify them with statistical 
confidence. The extent of recombination and the extreme dif-
ferences in SNP density between the K1 and K15 genes com-
pared to the central genes make phylogenetic relationships of 
large regions of the genome difficult to interpret and prevent 
the accurate identification of the ancestry of strains at this stage. 
Recombination suggests that at a particular time reinfection or 
simultaneous coinfection by multiple strains occurred in single 
cells of an individual; however, disentangling intrahost genomic 
diversity as a result of mixed infections or reinfections from 
on-going evolution is nontrivial, particularly for a virus with 
such high identity across strains. It is unclear when, where, and 
how this process occurs as this requires prior knowledge about 
the parental strains involved in the process, which we cannot 
ascertain in this study. While we cannot exclude the possibil-
ity of mixed infections, to robustly confirm the distribution of 
genomic mixtures, multiple samples for the same individuals 
across time and/or compartments [49] would be advantageous.
In conclusion, recombination across the KSHV genome 
contributes to the divergence of 5 proposed distinct types, des-
ignated here P1, P2, M1, M2, and N, and 1 potentially novel 
type that has not been well sampled, including the sole genome 
ZM004. Given that these data are based on the analyses of 70 
genomes, it is likely that the recombination events reported here 
are still an underestimation. Therefore, given our limitations, 
greater sampling depth from other parts of the world provid-
ing a more comprehensive global dataset, would be essential to 
examine the full extent of recombination in KSHV genomes. 
We speculate that certain types may contribute to virus trans-
missibility, which could be a very important contributing factor 
for why Uganda sustains such a high KSHV prevalence com-
pared to other parts of the world. It would be essential to inves-
tigate the functional consequences of these new types on viral 
pathogenesis. Furthermore, the existence of such recombina-
tion should be considered in any phylogenetic analysis of KSHV 
sequence data, and viral characterization based on whole-ge-
nome diversity needs to be considered coupled with a reassess-
ment of the nomenclature to accurately classify genotypes.
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